Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration

Denosumab is a human monoclonal antibody indicated for the treatment of osteoporosis in postmenopausal women with a high risk of fractures. To our knowledge, no cases of desensitization to this drug have been described in the literature. We report the first case of generalized urticarial reaction an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez-Fernández, D., Cruz, María-Jesús, Foncubierta-Fernández, A., Moreno-Ancillo, A., Fernández-Anguita, M. J., Medina-Varo, F., Andres-García, J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620716/
https://www.ncbi.nlm.nih.gov/pubmed/26504466
http://dx.doi.org/10.1186/s13223-015-0097-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620716/
https://www.ncbi.nlm.nih.gov/pubmed/26504466
http://dx.doi.org/10.1186/s13223-015-0097-6

Ejemplares similares